.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Julphar
Citi
Novartis
Argus Health
Cipla
Cantor Fitzgerald
UBS
Mallinckrodt

Generated: December 14, 2017

DrugPatentWatch Database Preview

GABLOFEN Drug Profile

« Back to Dashboard

Which patents cover Gablofen, and what generic alternatives are available?

Gablofen is a drug marketed by Piramal Critical and is included in one NDA.

The generic ingredient in GABLOFEN is baclofen. There are eighteen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the baclofen profile page.
Drug patent expirations by year for GABLOFEN

Pharmacology for GABLOFEN

Medical Subject Heading (MeSH) Categories for GABLOFEN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Piramal CriticalGABLOFENbaclofenINJECTABLE;INTRATHECAL022462-001Nov 19, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Piramal CriticalGABLOFENbaclofenINJECTABLE;INTRATHECAL022462-003Nov 19, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Piramal CriticalGABLOFENbaclofenINJECTABLE;INTRATHECAL022462-002Nov 19, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Piramal CriticalGABLOFENbaclofenINJECTABLE;INTRATHECAL022462-004Jun 22, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Colorcon
Healthtrust
Mallinckrodt
UBS
Harvard Business School
Cipla
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot